Big Move For UroGen Pharma Ltd.
Thu, Jun 12, 2025 at 07:27 PM
UroGen Pharma Ltd. (URGN:NASDAQ) shot up at $11.08, a gain of 51.8%. On Thu, Jun 12, 2025, URGN:NASDAQ touched a New 2-Week High of $11.08. The stock appeared on our News Catalysts scanner on Thu, Jun 12, 2025 at 04:11 PM in the 'BIOTECH' category. From Thu, May 29, 2025, the stock recorded 80.00% Up Days and 63.64% Green Days
About UroGen Pharma Ltd. (URGN:NASDAQ)
UroGen Pharma Ltd is a clinical stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies.
Top 10 Gainers:
- Greenlane Holdings, Inc. (GNLN:NASDAQ), 100%
- Creative Global Technology Holdings Limited (CGTL:NASDAQ), 98.29%
- Liminatus Pharma, Inc. (LIMN:NASDAQ), 82.81%
- Smart for Life, Inc. (SMFL:NASDAQ), 54.65%
- UroGen Pharma Ltd. (URGN:NASDAQ), 51.78%
- Signature Bank (SBNY:NASDAQ), 44.44%
- Distoken Acquisition Corporation (DIST:NASDAQ), 42.13%
- Sagimet Biosciences Inc. (SGMT:NASDAQ), 39.1%
- Klotho Neurosciences, Inc. (KLTO:NASDAQ), 37.93%
- CureVac N.V. (CVAC:NASDAQ), 37.59%